Quantcast

Latest Vaccination Stories

2014-07-28 13:14:57

University of Leeds Giving parents access to a website containing information about the measles, mumps and rubella (MMR) vaccine is the most cost-effective way of increasing its uptake, new University of Leeds research has found. Informing parents about the vaccine via a website containing information helping parents make a decision about MMR is on average £9.20 cheaper per vaccination to the NHS than informing them solely via a GP consultation, and £7.17 cheaper than via a leaflet...

2014-07-23 08:30:15

BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014. The Beijing CDC plans to order a minimum of 1.2 million doses of the seasonal flu vaccine this year from four domestic vaccine manufacturers for its...

2014-07-22 08:32:20

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season - SWIFTWATER, Pa., July 22, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone(®) (Influenza Vaccine) for the 2014-2015 influenza ("the flu") season have been released by the U.S. Food and Drug...

2014-07-21 23:02:00

New research report “OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020” prepared by GlobalData is now available at MarketPublishers.com. According to the study, the live-attenuated vaccines are forecast to dominate the dengue vaccine market through to 2020. London, UK (PRWEB) July 21, 2014 Deemed to be responsible for over 100 million infections each year, the dengue virus (DENV) is the world’s most prevalent arthropod-borne virus. The live-attenuated...

2014-07-17 12:29:49

MERIDEN, Conn., July 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that they have partnered with physicians from Velocity Urgent Care and launched a new initiative called Health-At-Work that offers on site influenza and other vaccinations to employers in Connecticut and surrounding regions. Unlike many vaccination providers, Health-At-Work offers the egg-free, highly pure Flublok influenza vaccine in the convenience of the employer's workplace. Employers can...

2014-07-16 04:21:39

TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome Program to identify the most relevant targets for cancer immunotherapies immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against cancer, today announces that it has...

polio vaccine
2014-07-13 04:59:37

Rebekah Eliason for redOrbit.com - Your Universe Online In the 1960s, a type of polio vaccine injected into the arm was discontinued. New study suggests that re-introducing this vaccine may help eradicate the disease. This study by Imperial College London and the Christian Medical College in Vellore, India, suggests that using the injected polio vaccine (IPV) may provide longer lasting protection against infection if it is used in conjunction with the commonly used live oral polio...

2014-07-10 08:28:03

The Focus Autism Foundation Investigates Autism Speaks' Shifting Stance on Vaccine Safety Research WATCHUNG, N.J., July 10, 2014 /PRNewswire-iReach/ -- There was a time when the world's largest autism charity strongly urged the U.S. government to examine the possibility of a vaccine-autism link. "We believe that the question of whether immunization is associated with an increased risk for ASD [Autism Spectrum Disorder] is of extremely high priority" wrote Dr. Geraldine Dawson, former...

2014-07-09 08:20:35

Milestone Achieved under $9.4 Million NIAID Cooperative Grant PRINCETON, N.J., July 9, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the combination of RiVax(TM) and VeloThrax(TM) induces protective immunity to...

2014-07-08 12:28:38

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season's manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will enable delivery on time to...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related